CBD Life Sciences, Inc. (CBDL)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
CBD Life Sciences Gross Profit Margin (Quarterly) : 95.45% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.45% |
| March 31, 2026 | 41.84% |
| December 31, 2025 | 41.84% |
| September 30, 2025 | 24.80% |
| June 30, 2025 | 3.12% |
| March 31, 2025 | 43.12% |
| December 31, 2024 | 39.66% |
| September 30, 2024 | 50.00% |
| June 30, 2024 | 40.31% |
| March 31, 2024 | 41.36% |
| December 31, 2023 | 8.61% |
| September 30, 2023 | -3.10% |
| June 30, 2023 | -26.28% |
| March 31, 2023 | -63.17% |
| December 31, 2022 | -167.2% |
| September 30, 2022 | -308.7% |
| June 30, 2022 | -137.4% |
| March 31, 2022 | -143.2% |
| December 31, 2021 | -295.4% |
| September 30, 2021 | -370.7% |
| June 30, 2021 | -381.2% |
| March 31, 2021 | -71.19% |
| December 31, 2020 | -1.51K% |
| September 30, 2020 | 7.44% |
| June 30, 2020 | 18.10% |
| Date | Value |
|---|---|
| March 31, 2020 | 51.65% |
| December 31, 2019 | 43.40% |
| September 30, 2019 | 36.75% |
| June 30, 2019 | 32.76% |
| March 31, 2019 | 47.06% |
| December 31, 2018 | |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.00% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ashland, Inc. | 27.16% |
| Achieve Life Sciences, Inc. | -- |
| BioAdaptives, Inc. | 54.00% |
| BellRing Brands, Inc. | 27.80% |
| Aspire-Lakewood Holdings, Inc. | 19.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.70% |
| Return on Assets | -1.62% |
| Return on Invested Capital | -1.71% |
| Profit Margin (Quarterly) | 46.21% |
| Operating Margin (Quarterly) | 44.70% |
| Return on Net Operating Assets | -9.33% |